The Future is Bright for Stem Cell Treatments
Considering the many emerging research studies on possible cord blood and cord tissue stem cell use, the future of stem cell treatments is very bright. Only the surface has been scratched when it comes to discovering the potential of these cells to treat diseases and disorders. New technologies that allow for the expansion of cord blood cells means that effective autologous therapy will be achievable well into adulthood. Additionally, research has shown that cord blood stem cells can also be effectively used for regeneration or repair, of non-hematopoietic tissues, such as the repair of joint damage through cartilage regeneration. Studies have also demonstrated that these cells are effective at modulating/reducing inflammation, and in the treatment of neurological disorders (ie. ALS, Alzheimer’s Disease, Stroke) that can occur later in life. Keeping up with the latest news inspires hope in the future.
New Study: Cord Tissue May Hold Benefits in Multiple Sclerosis
A new study followed 20 people with a median age of 41 who have been afflicted with multiple sclerosis for an average of nearly 8 years and underwent an infusion of cord tissue stem cells to treat the condition. It found that subjects experienced an improvement in their symptoms one month after treatment, and that was sustained for one year in many cases.
Report: Cord Blood Enhances Liver Disease Therapies
A meta-analysis of 10 studies conducted in the People's Republic of China shows that patients with liver cirrhosis who received cord blood transplantation with routine supportive therapies did better than those who received routine therapies alone.
Stem Cells Better Treatment Alternative to Deadly Autoimmune Disease Scleroderma
Stem cell transplants following chemotherapy and total-body irradiation were shown to significantly increase survival rates and a reduced the likelihood of relapse in people with scleroderma. Some were even left disease-free. At the end of the six-year period for which the participants were followed, the overall survival rate was 86% for those that received the stem cell transplant and only 51 percent for those who received the customary cyclophosphamide immune-suppressant injections.
Duke Granted Expanded Access in Autism and Cerebral Palsy Trials
Duke University Medical Center received permission to expand access to cord blood therapies for brain disorders including autism and cerebral palsy. The clinical trial is open to children who have their own cord blood stored or access to partially or fully matching cord blood from a sibling.
In the News: Cord Tissue for Cleft Repair
The University of Texas is developing a technique that uses the cord tissue to repair aveolar clefts, which affects the gum line and frontal areas of the roof of the mouth and can cause clefts in the lips and palate.
Duke University Releases Results on Phase I Autism Trial
Duke University has released the results from its preliminary, phase I study on the safety of treating autistic children with an intravenous infusion of their own umbilical cord blood.
Cord tissue to treat arthritis is for the dogs—too
The stem cells in umbilical cord blood and tissue aren’t just for humans; other mammals, such as man’s best friend, may be able to benefit, too.
Umbilical cord tissue stem cells can effectively reduce abnormal immune system activity in multiple sclerosis
In a recent study published in the journal Oncotarget
, researchers demonstrated that stem cells derived from umbilical cord tissue can effectively reduce abnormal immune system activity in patients suffering from multiple sclerosis (MS).
New Strategy for Treating Parkinson's Disease
Researchers have developed a new approach to using stem cells to treat Parkinson’s disease while avoiding the negative consequences of other stem cell therapies, according to two new studies.
The scientists used a type of human stem cells called mesenchymal stem cells, which are found in bone marrow and cord tissue. The cells respond to the environment that surrounds them, and when injected into the brains of mice with Parkinson’s disease, successfully became mature neurons and allowed for the physical recovery of the animals.
Cord blood stem cells may help restore vision for those suffering from macular degeneration
A phase 2 clinical trial is underway for the use of stem cells from umbilical cord blood to treat the most common form of macular degeneration. Researchers believe that that the treatment may not only stop the disease’s progression and thereby prevent its worse effects, but in fact, restore vision.